Is there a paraneoplastic ALS?

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 16, Issue 3-4, 2015, Pages 252-257

  Corcia, Philippe ^a,b   Gordon, Paul H ^c   Camdessanche, Jean Philippe ^d  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b CHU BRETONNEAU   (France)

^c INDIAN HEALTH SERVICE   (United States)

^d UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Motor neuron diseases; Paraneoplastic; Review

Indexed keywords

AUTOANTIBODY; HU ANTIBODY; RI ANTIBODY; UNCLASSIFIED DRUG; YO ANTIBODY; ANTIBODY; CDR2 PROTEIN, HUMAN; NERVE PROTEIN; RIBONUCLEASE INHIBITOR, BRAIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODY TITER; ARTICLE; BREAST CANCER; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; HEMATOLOGIC MALIGNANCY; HEREDITARY MOTOR SENSORY NEUROPATHY; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; LUNG ADENOCARCINOMA; LYMPHOMA; MOTOR NEURON DISEASE; NEOPLASM; NONHODGKIN LYMPHOMA; ONSET AGE; PARANEOPLASTIC NEUROPATHY; PARANEOPLASTIC SYNDROME; PRIMARY LATERAL SCLEROSIS; PRIORITY JOURNAL; SOLID; ADULT; AGED; CASE REPORT; COMPLICATION; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PATHOPHYSIOLOGY;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NERVE TISSUE PROTEINS; PARANEOPLASTIC SYNDROMES;

EID: 84929723387     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2014.965178     Document Type: Article

References (30)

1. Wijesekera L C, Leigh P N. A myotrophic lateral sclerosis. Orphanet Journal of Rare Diseases. 2009 ; 4 :3 doi:10.1186/1750-1172-4-3
2. Fang F, Al-Chalabi A, Ronnevi L, Turner M, WirDefeldt K, Kamel F, et al. Amyotrophic lateral sclerosis and cancer: a register-based study in SweDen. Amyotroph Lateral Scler Frontotemporal Degener. 2013 ; 14 : 362-8
3. Freedman D, Curtis R, Daughertt S, GoeDert J, Kuncl R, Tucker M. The association between cancer and amyotrophic lateral sclerosis. Cancer Causes Control. 2013 ; 24 : 55-60
4. Freedman D, Wu J, Daugherty S, Kuncl R, Enewold E, Pfeiffer R. The risk of amyotrophic lateral sclerosis after cancer in US eDerly adults: a population based prospective study. Int J Cancer. 2014 ; 135 : 1745-50
5. Darnell RB, Posner JB. P araneoplastic syndromes involving the nervous system. N Engl J Med. 2003 ; 349 : 1543-54
6. Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G, et al. Paraneoplastic neurologic syndrome in the PNS. Euronetwork Database. Arch Neurol. 2010 ; 67 : 330-5
7. Graus F, Delattre J Y, Antoine J C, Dalmau J, Giometto B, Grisold W, et al. RecommenDed diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004 ; 75 : 1135-40
8. Lee J, Macht S, Albrecht P, Hartung HP, Goebels N. Brachial amyotrophic diparesis associated with anti-Hupositive anterior horn cell disease and autonomic disorDer. J Neurol. 2013 ; 260 : 301-2
9. Verma A, Berger J, Snodgrass S, Petito C. M otor neuron disease: a paraneoplastic process with anti-Hu antibody and small-cell lung carcinoma. Ann Neurol. 1996 ; 40 : 112-6
10. Forsyth PA, Dalmau J, Graus F, Cwik V, Rosenblum MK, Posner JB. Motor neuron syndromes in cancer patients. Ann Neurol. 1997 ; 41 : 722-30
11. Younger D, Graber J, Hayakawa-Yano Y, Parveen S, Frank M, Darnell R. RI/NOVA gene-Associated paraneoplastic subacute motor neuronopathy. Muscle Nerve. 2013 ; 47 : 617-8
12. Khwaja S, Sripathi N, Ahmad K K, Lennon V. P araneoplastic motor neuron disease with type 1 Purkinje cell antibodies. Muscle Nerve. 1998 ; 21 : 943-5
13. Garcia Martin G, Perez Errazquin F, Chamoro Munoz M, Romero Acebal M. Amyotrophic lateral sclerosis and anti-CV2 antibodies. Paraneoplastic association? Neurologia. 2007 ; 22 : 406-9
14. Ferracci F, Fassetta G, Butler M, Floyd S, Solimena M, De Camilli P. A novel anti-neuronal antibody in a motor neuron syndrome associated with breast cancer. Neurology. 1999 ; 53 : 852-5
15. Berghs S, Ferracci F, Maksimova E, Gleason S, Leszczynsk N, Butler M, et al. Autoimmunity to a IV spectrin in paraneoplastic lower motor neuron syndrome. Proc Natl Acad Sci. 2001 ; 98 : 6945-50
16. Stich O, Kleer B, Rauer S. A bsence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease. J Neurol Neurosurg Psychiatry. 2007 ; 78 : 883-5
17. Gordon PH, Rowland L P, Younger DS, Sherman WH, Hays AP, Louis ED, et al. Lymphoproliferative disorDers and motor neuron disease: an update. Neurology. 1997 ; 48 : 1671-8
18. Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology. 2011 ; 76 : 705-10
19. Flanagan E, Sandroni P, Pittock S, Inwards D, Jones L. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve. 2012 ; 46 : 823-7
20. Schold SC, Cho ES, Somasundaram M, Posner JB. Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol. 1979 ; 5 : 271-87
21. Corcia P, Honnorat J, Guennoc AM, De Toffol B, Autret A. Scl e rose lat e rale primitive et cancer du sein: syndrome neurologique paran e oplasique ou association fortuite ? Rev Neurol. 2000 ; 156 : 1020-2
22. Sadot E, Carluer L, Corcia P, Delozier Y, Levy C, ViaDer F. Breast cancer and motor neuron disease: clinical study of seven cases. Amyotroph Lateral Scler. 2007 ; 5 : 288-91
23. Mitchell D M, Olczak S A. R emission of a syndrome indistinguishable from motor neuron disease after resection of bronchial carcinoma. Br Med J. 1979 ; 2 : 176-7
24. EVans B, Fagan C, Arnold T, Dropcho E, Oh S. P araneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy. Neurology. 1990 ; 40 : 960-2
25. Turk HM, Ozet A, Kuzhan O, Komurcu F, Arpaci F, Ozturk B, et al. Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma. Med Princ Pract. 2009 ; 18 : 73-5
26. Coban A, Ulusoy C, Giris M, Turan S, Turkoglu R, Tuzun E, et al. Serum anti-neuronal antibodies in amyotrophic lateral sclerosis. Int J Neurosci. 2013 ; 123 : 557-62
27. Younes-Mhenni S, Janier MF, Cinotti L, Antoine JC, Tronc F, Cottin V, et al. FDG-PET improves tumour Detection in patients with paraneoplastic neurological syndromes. Brain. 2004 ; 127 : 2331-8
28. Antoine JC, CamDessanche JP. P araneoplastic syndromes of the peripheral nervous system. Press Med. 2013 ; 42 : 235-44
29. Antoine J C, CamDessanche J P. T reatment options in paraneoplastic syndromes of the peripheral nervous system. Curr Treat Opinions Neurol. 2013 ; 15 : 210-23
30. Drlicek M, Bianch G, Bogliun G, Casati B, Grisold W, Kolig C, et al. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. J Neurol. 1997 ; 244 : 85-9